Advertisement

Hereditary Mixed Polyposis Syndrome and Multiple Adenoma Patients

  • Huw ThomasEmail author
Chapter
Part of the M.D. Anderson Solid Tumor Oncology Series book series (MDA, volume 5)

Abstract

Hereditary mixed polyposis syndrome (HMPS) is an extremely rare condition characterized by early age onset colorectal cancer and a variety of colorectal polyps of mixed histology. The genetic defect has been mapped in several Ashkenazi kindreds to chromosome 15q. In this chapter HMPS will be discussed.

Keywords

Hereditary Mixed Polyposis Syndrome Multiple Adenoma Patients 

References

  1. 1.
    Tomlinson I, Rahman N, Frayling I, Mangion J, Barfoot R, Hamoudi R, et al. Inherited susceptibility to colorectal adenomas and carcinomas: evidence for a new predisposition gene on 15q14-q22. Gastroenterology. 1999;116:789–95.PubMedCrossRefGoogle Scholar
  2. 2.
    Jaeger EE, Woodford-Richens KL, Lockett M, Rowan AJ, Sawyer EJ, Heinimann K, et al. An ancestral Ashkenazi haplotype at the HMPS/CRAC1 locus on 15q13-q14 is associated with hereditary mixed polyposis syndrome. Am J Hum Genet. 2003;72:1261–7.PubMedCrossRefGoogle Scholar
  3. 2A.
    Jaeger E, Webb E, Howarth K, Carvajal-Carmona L, Rowan A, Broderick P, et al. Common genetic variants at the CRAC1 (HMPS) locus on chromosome 15q13.3 influence colorectal cancer risk. Nat Genet. 2008;40:26–8.Google Scholar
  4. 3.
    Whitelaw SC, Murday VA, Tomlinson IP, Thomas HJ, Cottrell S, Ginsberg A, et al. Clinical and molecular features of the hereditary mixed polyposis syndrome. Gastroenterology. 1997;112:327–34.PubMedCrossRefGoogle Scholar
  5. 4.
    Rozen P, Samuel Z, Brazowski E. A prospective study of the clinical, genetic, screening, and pathologic features of a family with hereditary mixed polyposis syndrome. Am J Gastroenterol. 2003;98:2317–20.PubMedCrossRefGoogle Scholar
  6. 5.
    Bariol C, Hawkins NJ, Turner JJ, Meagher AP, Williams DB, Ward RL. Histopathological and clinical evaluation of serrated adenomas of the colon and rectum. Mod Pathol. 2003;16:417–23.PubMedCrossRefGoogle Scholar
  7. 6.
    Lugli A, Jass JR. Types of colorectal adenoma. Verh Dtsch Ges Pathol. 2006;90:18–24.PubMedGoogle Scholar
  8. 7.
    Thomas HJ, Whitelaw SC, Cottrell SE, Murday VA, Tomlinson IP, Markie D, et al. Genetic mapping of hereditary mixed polyposis syndrome to chromosome 6q. Am J Hum Genet. 1996;58:770–6.PubMedGoogle Scholar
  9. 8.
    Sneddon JB, Zhen HH, Montgomery K, van de Rijn M, Tward AD, West R, et al. Bone morphogenetic protein antagonist gremlin 1 is widely expressed by cancer-associated stromal cells and can promote tumor cell proliferation. Proc Natl Acad Sci USA. 2006;103:14842–7.PubMedCrossRefGoogle Scholar
  10. 9.
    Seidah NG, Chretien M. Proprotein and prohormone convertases: a family of subtilases generating diverse bioactive polypeptides. Brain Res. 1999;848:45–62.PubMedCrossRefGoogle Scholar
  11. 10.
    Dove-Edwin I, de Jong A, Lipton L, Adams J, Mesher D, Sasieni P, et al. Prospective results of surveillance colonoscopy in dominant familial colorectal cancer with and without Lynch syndrome. Gastroenterology. 2006;130:1995–2000.PubMedCrossRefGoogle Scholar
  12. 11.
    Laken SJ, Petersen GM, Gruber SB, Oddoux C, Ostrer H, Giardiello FM, et al. Familial colorectal cancer in Ashkenazim due to hypermutable tract in APC. Nat Genet. 1997;17:79–83.PubMedCrossRefGoogle Scholar
  13. 12.
    Frayling IM, Beck NE, Ilyas M, Dove-Edwin I, Goodman P, Pack K, et al. Tomlinson IPM. Proc Natl Acad Sci. 1998;95:10722–7.PubMedCrossRefGoogle Scholar
  14. 13.
    Thirlwell C, Howarth KM, Segditsas S, Guerra G, Thomas HJW, Phillips RKS, et al. Tomlinson IPM investigation of pathogenic mechanisms in multiple adenoma patients without germline APC or MYH/MUTYH mutations. Br J Cancer. 2007;96:1729–34.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  1. 1.Department of Surgery & CancerSt. Marks Hospital, Northwick Park Harrow and Imperial College LondonLondonUK

Personalised recommendations